stockrowEstablishment Labs Holdings Inc. (ESTA) vs NovoCure Limited (NVCR)
- Establishment Labs Holdings Inc. ESTA 67.34 +4.53%
- NovoCure Limited NVCR 13.47 −0.59%
Establishment Labs Holdings Inc. and NovoCure Limited are both Medical Devices companies. Establishment Labs Holdings Inc. is the larger, with a market value of $1.9B against $1.6B — 1.2× the size. Establishment Labs Holdings Inc. grew revenue faster over the last twelve months: 38.6% against 12.9%. Establishment Labs Holdings Inc. has the higher net margin (−15.8% vs −16.8%) and the higher return on invested capital (−5.53% vs −106.1%). Across the 18 metrics below, Establishment Labs Holdings Inc. leads on 9 and NovoCure Limited on 9.
Valuation
Profitability
| Metric | ESTA | NVCR | Medical Devices median |
|---|---|---|---|
| Gross margin | 70.49% | 77.02% | 57.76% |
| Operating margin | (7.63%) | (17.17%) | (15.07%) |
| Net margin | (15.82%) | (16.78%) | (14.45%) |
| Free cash flow margin | (16.90%) | (3.39%) | (3.88%) |
| Return on equity | (175.30%) | (35.18%) | (10.35%) |
| Return on assets | (11.41%) | (11.12%) | (17.26%) |
| Return on invested capital | (5.53%) | (106.10%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack